OBJECTIVE: To compare the efficacy of 0.6 % Ofloxacin eardrops with 0.3% Gentamicin eardrops in the management of active tubotympanic chronic otitis media. STUDY DESIGN: Quasi experimental study st th PLACE AND DURATION OF STUDY: ENT department, CMH Rawalpindi, from 1 June 2007 to 30 May 2008. PATIENTS AND METHODS: Total 100 consenting patients with the diagnosis of active tubotympanic chronic otitis media filling the inclusion criteria were included in the study. Six patients lost to followup, five were resistant to Gentamicin and three to Ofloxacin were excluded. Patients were randomly allotted to either the Group-I that was treated by Ofloxacin eardrops (n = 50) or to Group-II, treated by Gentamicin eardrops (n = 50). Outcomes were measured by disappearance of discharge and congestion from middle ear and external auditory canal at weekly follow-up examinations for 3 weeks. RESULTS: Ototopical ofloxacin was found more effective in providing relief from congestion and discharge as compared to gentamicin, in active tubotympanic chronic otitis media. CONCLUSION: Topical Ofloxacin is a better drug for the treatment of active tubotympanic type of chronic otitis media as compared to topical Gentamicin.